covid semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic GLP-1 Therapy and COVID Recovery:

Mar 28 2021;125(6):657-668

Desiree Granados Quick Summary: GLP-1 medications may reduce obstructive sleep apnea severity indirectly by promoting significant weight loss and improving metabolic health, which can decrease upper airway obstruction and inflammation

530 Walnut Street, Philadelphia, PA 19106 USA:Lippincott Williams & Wilkins

Research has examined its effects on body weight reduction, appetite regulation, metabolic outcomes, and combination therapy with semaglutide for obesity management and metabolic disease research

Backed By Medical Experts Every formulation is developed and overseen by experienced physicians, ensuring the highest standards of safety, precision, and effectiveness

doi: 10.1038/nrc3246 60 HuangJYangBPengYHuangJWongSHDBianLet al